Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors

Type: Retraction
Notice date: 5/9/2023 0:00
Journal: Lung Cancer: Journal of the International Association for the Study of Lung Cancer
Publisher: Elsevier
Notice DOI: 10.1016/j.lungcan.2023.107226
Original paper DOI: 10.1016/j.lungcan.2010.06.005

Reasons